Related content

DNA methylation analysis of SFRP2, GATA4/5, NDRG4 and VIM for the detection of colorectal cancer in fecal DNA

By                

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1751-1756

Spandidos Publications

Access to resources Recommend Favorite

Aberrant promoter DNA methylation inhibits bone morphogenetic protein 2 expression and contributes to drug resistance in breast cancer

By Du Min   Su XiaoMei   Zhang Tao   Xing YongJun  

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-08 ,pp. : 1051-1055

Spandidos Publications

Access to resources Recommend Favorite

Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma

By Banzai Chiaki   Nishino Koji   Quan Jinhua   Yoshihara Kosuke   Sekine Masayuki   Yahata Tetsuro   Tanaka Kenichi  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 127-132

Springer Publishing Company

Access to resources Recommend Favorite

Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis

By Shi Dong-Tao   Han Mei   Gao Nan   Tian Wenyan   Chen Weichang  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 943-948

Springer Publishing Company

Access to resources Recommend Favorite

Methylation analysis of the DAPK1 gene in imatinibresistant chronic myeloid leukemia patients

By  

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 399-404

Spandidos Publications

Access to resources Recommend Favorite